Home›Stock Screener›Sanofi Consumer Healthcare

Sanofi Consumer Healthcare Share Price Today | Stock Price & Sanofi Consumer Healthcare Share Screener

SANOFICONR Pharmaceuticals & Biotechnology
Live Share Price NSE
₹3532.30
▼ -0.10 (0.00%)
2026-11-18 00:00:00
Live Share Price BSE
₹3528.50
▲ 2.55 (0.07%)
2026-11-18 00:00:00

As of November 18, 2026, the live Sanofi Consumer Healthcare share price (NSE: SANOFICONR) is ₹3,532.30 on NSE and ₹3,528.50 on BSE, down 0.00% from the previous close, with shares trading between ₹3,489.70 and ₹3,555.90 in today's trading session, and a 52-week range of ₹3,207.90–₹5,026.80. Track SANOFICONR company valuation to gauge the company's total market size. Use the Sanofi Consumer Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sanofi Consumer Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹1,000 and net income of ₹280, with EBITDA of ₹391, an operating margin of 38.0% and a profit margin of 28.0%.

Sanofi Consumer Healthcare Market Cap ₹8,135.34 Cr.
SANOFICONR P/E Ratio (TTM) 29.80
Sanofi Consumer Healthcare P/B Ratio 23.94
EPS (TTM) ₹92.57
Dividend Yield 2.07%
Debt to Equity 0.07
SANOFICONR 52 Week High ₹5026.80
Sanofi Consumer Healthcare 52 Week Low ₹3207.90
Operating Margin 38.00%
Profit Margin 28.00%
SANOFICONR Revenue (TTM) ₹1,000.00
EBITDA ₹391.00
Net Income ₹280.00
Total Assets ₹547.00
Total Equity ₹384.00

Sanofi Consumer Healthcare Share Price Chart

Track the current stock price of Sanofi Consumer Healthcare with an interactive chart. Analyse SANOFICONR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sanofi Consumer Healthcare stock quote in one place.

The quote of ₹3,532.30 sits between the 52-week low of ₹3,207.90 and the 52-week high of ₹5,026.80, and the latest session moved 0.00% from the previous close.

Sanofi Consumer Healthcare Company Profile - Fundamental Screener

Screen Sanofi Consumer Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANOFICONR shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE0UOS01011.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE0UOS01011

Sanofi Consumer Healthcare Balance Sheet Screener

Screen SANOFICONR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹547, up from ₹431 in 2024.

Latest statistics put total assets at ₹547 and shareholder funds at ₹384, with a leverage ratio of 0.07.

Item 2025 2024 2023

Assets

Total Assets 547 431 345
Current Assets 0 0 0
Fixed Assets 36 29 5

Liabilities

Total Liabilities 0 0 0
Current Liabilities 35 28 8
Non-Current Liabilities 0 0 0

Shareholders' Equity

Total Equity 384 273 208
Share Capital 23 23 2
Reserves & Surplus 361 250 183

Sanofi Consumer Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Sanofi Consumer Healthcare income statement and profit fundamentals. Analyze SANOFICONR quarterly results. Sanofi Consumer Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹1,000 and net profit was ₹280, equal to earnings per unit of ₹121.40, at an operating margin of 38%.

In that period expenses were ₹609, interest cost ₹2 and tax ₹98. The next period listed, 2026-March, shows revenue of ₹728 and net profit of ₹211.

Item None-None 2026-March 2025-March 2024-March 2023-March

Revenue and Expenses

Revenue 1,000 728 897 738 560
Expenses 609 448 569 454 337

Operating Costs and Margins

EBITDA 391 280 327 284 223
Operating Profit % 38.00% 38.00% 35.00% 37.00% 39.00%
Depreciation 13 10 12 5 2
Interest 2 1 2 4 0

Profit and Earnings

Profit Before Tax 376 285 320 247 219
Tax 98 74 80 66 54
Net Profit 280 211 240 181 165
EPS 121.40 92.57 104.27 78.59 71.60

Sanofi Consumer Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen SANOFICONR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹175, and net cash flow was an inflow of ₹48.

Over the same period, investing activities provided ₹8 and financing activities used ₹135.

Item 2025-March 2024-March 2023-March

Cash from Operations and Investing

Operating Activities 175 439 0
Investing Activities 8 2 0

Financing and Net Cash

Financing Activities -135 -116 2
Net Cash Flow 48 325 2

Sanofi Consumer Healthcare Shareholding Pattern Screener

See Sanofi Consumer Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Sanofi Consumer Healthcare promoter holding and ownership changes for SANOFICONR on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 71.27%, foreign institutions 2.76%, domestic institutions 17.57% and the public 6.26%, spread across 48,418 shareholders.

The shareholder count was 48,418 in 2026-Mar, compared with 47,511 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Jun

Promoter Holding

Promoter Holding 71.27% 71.27% 71.27% 60.40% 71.27% 71.27% 71.27% 60.40%

Institutional Investors

FII Holding 2.76% 2.60% 2.48% 4.53% 3.24% 2.94% 2.83% 0.00%
DII Holding 17.57% 17.86% 18.03% 25.48% 16.89% 17.21% 17.33% 20.87%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 6.26% 6.18% 6.16% 6.58% 6.30% 6.26% 6.25% 7.71%
Other Holding 2.14% 2.10% 2.06% 3.01% 2.30% 2.32% 2.31% 11.03%
Shareholder Count 48,418 47,511 46,586 51,859 49,632 48,808 48,075 61,091

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sanofi Consumer Healthcare. Sanofi Consumer Healthcare dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹75.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹75.00 and ₹55.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹75.00 1.74%
2024-March ₹55.00 1.14%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Sanofi Consumer Healthcare Stock Index Membership - Nifty & Sensex

See which indices include Sanofi Consumer Healthcare stock. Check SANOFICONR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 4 indices, including BSE INDEX BSE HC.

Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250, NIFTY TOTAL MKT.

Complete Index List

BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT

Sanofi Consumer Healthcare Market Events Screener - Corporate Actions

Get Sanofi Consumer Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sanofi Consumer Healthcare stock events that may affect SANOFICONR share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 28, 2026, with a record date of October 28, 2026.

It is followed by Quarterly Result Announcement dated July 28, 2026 and Annual General Meeting dated June 26, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-28 2026-10-28 Quarterly Result Announcement NA 0.20%
2026-07-28 2026-07-28 Quarterly Result Announcement NA 2.37%
2026-06-26 2026-06-26 Annual General Meeting NA -0.48%
2026-06-19 2026-06-19 Dividend ₹ 75.00 /share 23.74%
2026-04-28 2026-04-28 Quarterly Result Announcement NA 1.44%
2026-02-25 2026-02-25 Quarterly Result Announcement NA -4.76%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -5.69%
2025-08-04 2025-08-04 Quarterly Result Announcement NA -2.10%
2025-05-05 2025-05-05 Annual General Meeting NA 3.98%
2025-05-02 2025-05-02 Quarterly Result Announcement NA 0.05%
2025-04-17 2025-04-17 Dividend ₹ 55.00 /share 5.10%
2025-02-20 2025-02-20 Quarterly Result Announcement NA 0.62%
2024-11-12 2024-11-12 Quarterly Result Announcement NA 0.78%

Sanofi Consumer Healthcare Competitors Screener - Peer Stocks Comparison

Screen SANOFICONR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,676 40.80 61,674 12.69% 11,565 60.46
Divis Laboratories 295,997 87.70 11,067 13.95% 2,568 68.76
Torrent Pharmaceuticals 177,586 85.00 13,886 20.34% 2,138 47.23
Laurus Labs 126,325 89.90 6,868 22.01% 890 57.04
Zydus Life Science 120,119 27.60 27,658 17.64% 5,026 55.91
Dr Reddys Laboratories 115,854 41.80 35,059 3.90% 4,158 71.26
Cipla 112,131 39.50 29,045 2.24% 3,870 53.06
Mankind Pharma 107,805 47.90 14,636 14.85% 1,938 61.37
Aurobindo Pharma 103,229 25.80 34,145 5.56% 3,503 60.39
Lupin 89,172 17.30 29,039 26.75% 5,356 39.39

Sanofi Consumer Healthcare Company Announcements - News & Reports Screener

Screen SANOFICONR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 9, 2026.

The next most recent announcements are dated November 6, 2026 and October 29, 2026.

Date Update Actions
2026-11-09 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-06 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-10-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-28 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-28 Results - Financial Results For September 30 2026 -
2026-10-28 Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday 28Th October 2026 -
2026-10-22 Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 30Th September 2026. -
2026-10-12 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-28 Closure of Trading Window -
2026-07-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-28 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-07-28 Results - Financial Results For June 30 2026 -
2026-07-28 Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 28Th July 2026 -
2026-07-22 Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026. -
2026-07-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-29 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-06-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-06-26 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-06-26 Closure of Trading Window -
2026-06-05 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹3,532.30, within a 52-week range of ₹3,207.90 to ₹5,026.80. The P/E ratio is 29.80 and the P/B ratio is 23.94, with earnings per unit of ₹92.57. Market capitalisation stands at ₹8,135.34 Cr and the dividend yield is 2.07%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 3 balance sheet periods, 5 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.